Jubilant HollisterStier Opens Third Manufacturing Line

Jubilant HollisterStier recently celebrated the opening of its third sterile fill finish manufacturing line and broke ground on the next phase of its facility expansion in Spokane, WA.

The expansion includes a new high-speed commercial fill finish line, which is part of a 50k sq. ft. facility expansion, increasing JHS’ production capacity by 55 million units per year. At 400 vials per minute, it’s equipped with full isolator technology and 100% weight-checking capabilities at production speeds. It also includes an additional three compounding suites with capacity for up to 2000 L bulks and disposable, single-use compounding and filling technologies. The line is also outfitted with two new 300-sq-ft lyophilizers.

JHS is currently scheduling time for client projects on the third manufacturing line and has broken ground on Phase 2 of their facility expansion for a fourth manufacturing line.

This project has been supported in whole or in part with federal funds from the U.S. Department of Health and Human Services, Administration for Strategic Preparedness and Response (ASPR), Biomedical Advanced Research and Development Authority (BARDA), under cooperative agreement award number IDSEP230067.

JHS President and CEO Chris Preti, the Consulate General of India Mr. Prakash Gupta, representatives from the United States Department of Health and Human Services, members of the Spokane City Council, and other key local and state decision makers were in attendance.

The event also featured a video message from State Representative Cathy McMorris Rodgers regarding the positive benefits the JHS’ expansion will have on the greater Spokane community, including the addition of 200+ new jobs.

Jubilant HollisterStier LLC, a subsidiary of Jubilant Pharmova Limited, is an integrated contract manufacturer of ophthalmics, sterile injectables, lyophilized products, and sterile ointments. We are committed to providing exceptional manufacturing services to the pharmaceutical and biopharmaceutical industries in North America. With two facilities located in Spokane, Washington and Montreal, Quebec, Canada, we ensure that your project is streamlined with a full range of support and services that it deserves by keeping and training the best talent. By investing in people with cross-functional training and development for critical roles, innovative equipment and predictive technologies, we are able to seize your project’s potential for next level performance at every opportunity. For more information, visit www.jublhs.com.